Efficacy and Safety Study of Ingavirin ® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Conditions:   Influenza, Human;   Acute Respiratory Infection;   Viral Infection;   Common Cold Interventions:   Drug: Ingavirin;   Drug: Placebo oral capsule Sponsors:   Valenta Pharm JSC;   Atlant Clinical Ltd. Completed - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials